Diabetes (type 1)
About this PSP
This PSP was financially supported by the Insulin Dependent Diabetes Trust, and had practical support from the NIHR Diabetes Research Network, Diabetes UK, Juvenile Diabetes Research Foundation, NHS Evidence - Diabetes, and the Scottish Diabetes Research Network. It was established in early 2010.
583 respondents to the initial survey submitted a total of 1,141 treatment uncertainties.
The Diabetes (Type 1) PSP Top 10 was published in May 2011.
See news about this PSP: March 2020
Articles and publications
Impact after the Top 10
Key documents
Top 10 priorities
- Is it possible to constantly and accurately monitor blood sugar levels, in people with type 1 diabetes, with a discreet device (non-invasive or invasive)
- Is insulin pump therapy effective? (immediate v deferred pump, and comparing outcomes with multiple injections)
- Is an artificial pancreas for type 1 diabetes (closed loop system) effective?
- What are the characteristics of the best type 1 diabetes patient education programmes (from diagnosis to long term care) and do they improve outcomes?
- What are the cognitive and psychological effects of living with type 1 diabetes?
- How can awareness of and prevention of hypoglycaemia in type 1 diabetes be improved?
- How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with type 1 diabetes?
- Does treatment of type 1 diabetics by specialists (e.g. doctors, nurses, dieticians, podiatrists, ophthalmologists and psychologists) trained in person-centred skills provide better blood glucose control, patient satisfaction and self-confidence in management of type 1 diabetes, compared to treatment by non specialists with standard skills?
- What makes self management successful for some people with type 1 diabetes, and not others?
- Which insulins are safest and have the fewest (long term) adverse effects?
Document downloads
To see more uncertainties identified for Diabetes (Type 1) see the document below